vialroom

#retatrutide 2025-02-08

Saturday45 messages10 participantstimes are UTC
Highlights from this day
  • month_six_me — im at 2.4 and the appetite effect is stronger than i expected, normal 19:03
  • still_here_2024 — the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me 21:06
  • split_dose_sam — sat at 10 for 9 months rather than climbing and it kept working, so i never went up 23:00
TS

TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule, n of 1 obviously

ST

right so there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists

TS

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

ST

follow up is the glucagon arm what people mean by the energy expenditure thing

janoshik-b-0329.pdf
2 pages · 823 KB · not retained in the public archive
MS

im at 2.4 and the appetite effect is stronger than i expected, normal

🤝9👍5
MS

nobody should read my log as a plan, im recording what i did and thats all it is

MS

GI was about the same as tirzepatide for me, the difference was how fast it arrived

MS

appetite suppression at 2.5 was stronger than my tirzepatide experience at a comparable point

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

settled by month three

does the glucagon arm explain the heart rate or is that unrelated

VB

Batch lookup A-2601: 9 independent reports on file, earliest 2024-11-13.

⚠️2
VB

Digest for the week of 2024-12-18 has been published.

TO

lost 48kg over 15 months at doses well under what the trials used

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial, still working it out

MM

is there any long term safety data at all or is it phase 2 and hope

reconstituted the 2 vial to 8mg/ml specifically so i could take 2 without measuring crumbs

blood pressure stayed flat for me while heart rate moved, which i didnt expect

phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan

SH

the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me

📉7📈10
SH

sorry to jump in the purity spread across lots worries me more than the molecule does, i have it written down somewhere

mine went up too

🎉5❤️5😂4

i said 6 months ago that my heart rate had settled and it has stayed settled since

🤝2🧊4

i log resting heart rate every morning because of this and its the one number i actually watch

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
SH

held at 0.25 for 10 months and it never plateaued for me, which i cant explain

PP

did the phase 2 plateau or was it still moving at the end

📈12
SD

right so the heart rate thing is real enough that i mention it whenever someone asks about starting
buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

SD

sat at 10 for 9 months rather than climbing and it kept working, so i never went up

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)
🧪11
SD

no idea whether the heart rate settles for everyone, mine did and one log isnt data